Sequential SPE Pretreatment for Urinary DNA Adductomics

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for analyzing DNA adducts in urine samples face challenges due to matrix interference from water, salts, and other metabolites, which can damage mass spectrometers and reduce signal clarity, necessitating improved sample pretreatment techniques for effective DNA adductomics.

Innovation Solution

A method involving sequential solid phase extraction (SPE) using hypercrosslinked, hydroxylated polystyrene-divinylbenzene copolymer and phenyl polymer stationary phases to isolate and elute DNA adducts, followed by liquid chromatography mass spectrometry (LC-MS) analysis, effectively removes interfering matrix components while retaining DNA adducts.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional syringe filters and dilution are used for sample pretreatment, then the process is simple and quick, but the interfering matrix components are not effectively removed while DNA adducts are retained

Engineering Contradiction:
Improvematrix removal efficiencyVSAvoidpretreatment process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The pretreatment process is segmented into multiple sequential SPE steps with different stationary phases (first SPE column for initial extraction, second SPE column for further purification). Each step targets specific matrix components while preserving DNA adducts, achieving comprehensive matrix removal through divided functional stages rather than a single complex step.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

SPE stationary phases act as intermediary materials that selectively interact with matrix components. The hypercrosslinked polystyrene-divinylbenzene copolymer and phenyl polymer stationary phases serve as mediators that trap interfering substances while allowing DNA adducts to pass through or be eluted in a purified form.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If extensive hydrolysis reactions are used to isolate DNA adducts, then DNA adducts can be effectively isolated, but the process becomes time-consuming and complex

Engineering Contradiction:
ImproveDNA adduct isolation efficiencyVSAvoidisolation process time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The method extracts and removes interfering matrix components directly from urine samples using SPE technology, eliminating the need for extensive hydrolysis reactions. By taking out the problematic matrix elements beforehand, the subsequent DNA adduct isolation becomes simpler and faster, as the adducts can be directly extracted from the pre-cleaned sample.

Inventive Principle:
Principle #2Taking out (Extraction)

3Ease of operation

If urine samples are used instead of blood or tissue, then noninvasive sampling is achieved, but matrix interference from water, salts and metabolites increases

Engineering Contradiction:
Improvesampling invasivenessVSAvoidmatrix interference
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

Preliminary SPE pretreatment is performed on urine samples before LC-MS analysis to remove interfering matrix components. This preliminary action cleans the sample in advance, eliminating water, salts, and metabolite interference that would otherwise damage the mass spectrometer and reduce signal clarity, while maintaining the noninvasive advantage of urine sampling.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly enhances the recovery and analysis of DNA adducts by reducing matrix interference, providing a robust and efficient method for urinary DNA adductomics, as demonstrated by high recovery rates of DNA adduct standards and effective detection of benzene-induced adducts in mouse urine.

Implementation Method 1

passing a mobile phase including the sample through a first solid phase extraction (SPE) stationary phase; passing a first eluent through the first SPE stationary phase to elute the DNA adducts

Methodology Applied
Scientific EffectAdsorption: Adsorption

Implementation Method 2

passing a mobile phase including the sample through a first solid phase extraction (SPE) stationary phase; collecting the mobile phase that passes through the first SPE stationary phase

Methodology Applied
Scientific EffectChromatography: Chromatography

Data Source

PatentUS20240376538A1Pretreatment method for DNA adductomics samples
Publication Date: 2024.11.14 UNIV OF SOUTH FLORIDA
  • US20240376538A1 patent drawing
  • US20240376538A1 patent drawing
  • US20240376538A1 patent drawing

AI summary

Disclosed is a method of pretreating a sample including DNA adducts for DNA adductomics, the method including the steps: passing a mobile phase including the sample through a first solid phase extraction (SPE) stationary phase; collecting the mobile phase that passes through the first SPE stationary phase; passing a first eluent through the first SPE stationary phase to elute the DNA adducts; passing the collected mobile phase that passed through the first SPE stationary phase through a second SPE stationary phase; passing a second eluent through the second SPE stationary phase to elute the DNA adducts; combining DNA adducts eluted from the first and second SPE stationary phases; analyzing the DNA adducts by liquid chromatography mass spectrometry (LC-MS); wherein either the first or second SPE stationary phase is a hypercrosslinked, hydroxylated polystyrene-divinylbenzene copolymer and the other SPE stationary phase is a phenyl polymer.